The brief commentary on guidelines for the management of atopic dermatitis 2009 - The point of drug treatment

Japanese Journal of Allergology

Volumn 58, Issue 12, 2009, Pages 1568-1573

  Saeki, Hidehisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atopic dermatitis; Drug treatment; Topical steroid; Topical tacrolimus

Indexed keywords

ATOPIC DERMATITIS; HUMAN; PRACTICE GUIDELINE; REVIEW;

DERMATITIS, ATOPIC; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84866630265     PISSN: 00214884     EISSN: 13477935     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Arellano FM, Wentworth CE, Arena A, Fernández C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 2007; 127: 808-16. (Pubitemid 46434650)
2. Kawashima M, Tango T. Noguchi T, Inagi M, Nakagawa H, Harada S. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol 2003; 148:1212-21. (Pubitemid 36819222)
3. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.